Plan ahead

Plan ahead of these events, and schedule time with us!

We can help you:

Understand

Understand the landscape in seconds for the targeted therapy of your choice.

Book a demo

To book a live demo to show you how this works specifically to your questions.

Events Beacon will be attending

3rd Gamma Delta T Therapies Summit

July 26-28, 2022 – Boston, MA

As newly published data show the first Gamma Delta T cell therapy’s clinical efficacy in patients, the race to market for the first allogeneic and solid tumor-targeting γδT has begun.

Join us at the 3rd Gamma Delta T Therapies Summit alongside 120+ of the world’s leaders in the field to discuss discovery to manufacturing and clinical development of these ‘holy grail’ therapies in allogeneic and solid tumor settings.

Developed with key opinion leaders such as Adrian Hayday, and experts from Adicet Bio, Lava Therapeutics, IN8 Bio, and many more, attend this meeting to engage in interactive discussions and gain the actionable insights to advance bench to commercial bedside development of γδT-based therapies.

Register Here

3rd Cytokine-Based Drug Development Summit 2022

July 26-29, 2022 | Boston, MA

The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address your biggest challenges in the cytokine field.

With 30+ expert speakers, including the hottest academic researchers and leading figures from the industry, this 4-day program is your opportunity to gain insight into the latest clinical advancement and have thought-provoking discussions about how to overcome the field’s greatest drug development challenges.

What can you expect to see?

  • Further your understanding of the underlying mechanisms of action, and T-cell exclusion from the tumor in order to turn cold tumors ‘hot’ with Ask-Gene Pharma
  • Optimize cytokine engineering to ensure stability and improve the favorable risk-benefit profile with Proviva Therapeutics
  • Leverage insights from the industry’s leading lights to overcome toxicity challenges by ensuring tumor targeting is selective and therefore enhances the anti-tumor response with Equilium, Cytonus Therapeutics & Cytimmune
  • Take a deep dive into preclinical cancer models covering both in vitro and in-vivo studies and how these are unveiling the most favored pharmaceuticals properties of therapeutic cytokines with Astra Zeneca & Xilio Therapeutics
  • Uncover the latest data coming out of the clinic of cytokines in combination with checkpoint inhibitors and monoclonal antibodies with Alkermes & NeoImmune Tech

Get your copy of the brand-new agenda for the full list of speakers and sessions.

To learn more about how Beacon’s Cytokine module solution can help you and your team reach your drug development goals click here.  

Register Here

13th World ADC San Diego 2022

September 6-9, 2022 | San Diego, USA

This September, Hanson Wade are excited to unite 600+ ADC enthusiasts and experts at the world’s definitive antibody-drug conjugate event.

The successes of 2021 are already being seen in 2022 with BLA submissions, more candidates entering the clinic, an ever-growing number of preclinical assets and positive results being shown in the subgroup of patients where previous treatments have failed – and the promise of ADCs to change the paradigm of oncology treatment is beginning to be realized. This meeting is designed to bring the community back-in person at the biggest and best event to date to help forward thinking researchers from biopharma advance the development of, and maximize, the clinical therapeutic index of ADCs.

Jia-He-Senior-ADC-Research-LeadBeacon’s own Jia He, Senior Research Lead for Beacon ADC, will be presenting at this global event, giving you the opportunity to see the power of Beacon Targeted Therapies ADC database solution. To view the full event guide click here.

You will also get the chance to meet the Beacon ADC team, see live demonstrations and ask questions about how Beacon ADC can give you the confidence to make faster and better decisions.

Register today to join us in San Diego this September.

To learn more about how Beacon’s ADC database solution can help you and your team click here.  

Find out more
World-ADC-San-Diego-2022-logo

Non-Small Cell Lung Cancer Drug Development Summit 2022

September 20-22, 2022 | Boston, MA

Despite the vast number of trials taking place within the NSCLC space it remains one of the highest tumor indications of unmet clinical need, with prevalence only set to increase. Focusing from late-line through to early-line, this conference will address how to supercharge your pipeline through implementing smart drug design; expert translational medicine; advanced trial design and patient recruitment; and evidence-based combination and sequencing rationale specific to NSCLC.

There has never been a more important time to attend the 2nd NSCLC Drug Development Summit. Join this dedicated and determined community uniting to defeat NSCLC and radically change patients’ lives.

Ahmed TajmohamedBeacon’s own Ahmed Tajmohamed, Research Analyst for Beacon Checkpoint, will be presenting at this global event, giving you the opportunity to see the power and detail of Beacon Targeted Therapies Checkpoint data. To view the full event guide click here.

You will get the chance to meet the Beacon Checkpoint team, see live demonstrations and ask questions about how Beacon Checkpoint can give you the confidence to make faster and better decisions.

Register today to join us in Boston this September.

To learn more about how Beacon’s Checkpoint database solution can help you and your team click here.  

Find out more

13th World Multispecifics Summit 2022

September 20-22, 2022 | Boston, MA

The newly re-branded 13th World Multispecifics Summit returns this September as the only end-to-end meeting committed solely to advancing the development of bi- & multi-specific therapeutics.

This world-renowned forum will deliver a greater scope and penetration of innovative technical content than ever before. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.

Whatever your role or interest, you will leave the meeting with concrete methods to employ in your strategy and pipeline to convert the promise of bi- and multi-specific therapeutics into a reality for patients.

Beacon Bispecific ResearcherBeacon’s own Shailee Patel, Research Analyst for the Beacon Bispecific module solution, will be opening day one of this global event by giving an enthralling lecture on The Landscape of Bi/Multispecifics and setting the scene for the rest of the expertly crafted agenda – download the full event guide here. You will get the chance to meet the Beacon Bispecific team, see live demonstrations and ask questions about how Beacon Bispecific can give you the confidence to make faster and better decisions.

Register today to join us in Boston this September.

To learn more about how Beacon’s Bispecific module solution can help you and your team click here.  

Find out more

Conference Tracker

Upcoming events

Due to the impacts of COVID-19, we will be monitoring the activities of key conferences, to find out more about how we monitor this, please view our conference tracker.

Conference Tracker

logo